Novel corticosteroid treatment data to be presented at ECE 2022
Share This
Twitter
Facebook
Sparrow Pharmaceuticals will be presenting novel pharmacological data on its candidates for treating corticosteroid excess on 24 May at the European Congress of Endocrinology (ECE 2022).
Our website uses cookies to provide you with a better online experience.
If you continue to use our site without changing your browser settings,
we'll assume you are happy to receive cookies.
Please read our cookie policy for more information.
